Pictet Asset Management (UK)’s Esperion Therapeutics ESPR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
$2.79M Buy
131,849
+2,460
+2% +$59.2K ﹤0.01% 960
2021
Q1
$3.63M Buy
129,389
+6,712
+5% +$198K ﹤0.01% 898
2020
Q4
$3.19M Sell
122,677
-4,000
-3% -$120K ﹤0.01% 902
2020
Q3
$4.71M Buy
126,677
+15,293
+14% +$606K 0.01% 738
2020
Q2
$5.71M Buy
111,384
+7,576
+7% +$317K 0.01% 648
2020
Q1
$3.27M Buy
103,808
+42,100
+68% +$2.22M 0.01% 751
2019
Q4
$3.68M Buy
+61,708
New +$2.77M 0.01% 829
2019
Q2
Sell
-437,518
Closed -$17.6M 1026
2019
Q1
$17.6M Buy
437,518
+52,467
+14% +$2.35M 0.04% 430
2018
Q4
$17.7K Sell
385,051
-7,262
-2% -$350K 0.04% 398
2018
Q3
$17.4M Buy
392,313
+46,642
+13% +$2.14M 0.04% 442
2018
Q2
$13.5M Buy
345,671
+57,117
+20% +$2.89M 0.03% 451
2018
Q1
$20.9M Sell
288,554
-54,839
-16% -$4.03M 0.05% 372
2017
Q4
$22.6M Buy
343,393
+36,938
+12% +$1.99M 0.06% 363
2017
Q3
$15.4M Buy
306,455
+33,574
+12% +$1.62M 0.04% 413
2017
Q2
$8.74M Buy
272,881
+144,339
+112% +$5.31M 0.03% 495
2017
Q1
$4.54M Buy
+128,542
New +$2.94M 0.01% 636

Other funds holding ESPR